Acadian Asset Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Acadian Asset Management’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-211,836	Closed	-$3K	–	1977
2023 Q1	$3K	Sell	211,836 -223,026	-51%	-$20.6K	﹤0.01%	1705
2022 Q4	$34K	Buy	+434,862	New	+$55.2K	﹤0.01%	1638

Other funds holding STAB

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Acadian Asset Management's STAB Position: Q2 2023 in Review

Acadian Asset Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2023, closing a stake of 211,836 shares — an estimated $3K sold.

Acadian Asset Management first reported a position in STAB in Q4 2022 and held it in 2 quarters. The position peaked at $34K in Q4 2022. 1 fund tracked by Wall St. Rank holds STAB as of Q2 2023.

Acadian Asset Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Acadian Asset Management sold 211,836 Statera Biopharma, Inc. Common Stock shares in Q2 2023, an estimated $3K.
Acadian Asset Management first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Acadian Asset Management's Statera Biopharma, Inc. Common Stock position peaked at $34K in Q4 2022.
1 fund tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2023.

Based on Acadian Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.